Cargando…

Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study

INTRODUCTION: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Agostino, Armando, Aguglia, Andrea, Barbui, Corrado, Bartoli, Francesco, Carrà, Giuseppe, Cavallotti, Simone, Chirico, Margherita, Ostinelli, Edoardo G., Zangani, Caroline, Martinotti, Giovanni, Ostuzzi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245273/ https://www.ncbi.nlm.nih.gov/pubmed/35773631 http://dx.doi.org/10.1186/s12888-022-04071-2

Ejemplares similares

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
por: Barbui, Corrado, et al.
Publicado: (2020)

The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
por: Aguglia, Andrea, et al.
Publicado: (2021)

Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study
por: Bertolini, Federico, et al.
Publicado: (2021)

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
por: Barbui, Corrado, et al.
Publicado: (2016)

Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
por: Ostuzzi, Giovanni, et al.
Publicado: (2018)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis
por: Zangani, Caroline, et al.
Publicado: (2021)

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
por: Meid, Andreas D., et al.
Publicado: (2017)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Physical health monitoring in antipsychotic depot clinic
por: Davies, Rebecca, et al.
Publicado: (2021)

Metabolic Syndrome Monitoring in Patients on Depot Antipsychotics
por: Ateem, Salah
Publicado: (2023)

Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
por: Turrini, Giulia, et al.
Publicado: (2017)

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis
por: Ostinelli, Edoardo G, et al.
Publicado: (2019)

Mental health services in Italy during the COVID-19 outbreak
por: D'Agostino, Armando, et al.
Publicado: (2020)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance
por: Ostuzzi, Giovanni, et al.
Publicado: (2017)

Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
por: Purgato, Marianna, et al.
Publicado: (2011)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

Patterns of prescription of antipsychotics in Qatar
por: Ouanes, Sami, et al.
Publicado: (2020)

Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics
por: Starace, Fabrizio, et al.
Publicado: (2018)

Treatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication
por: POPP, BIANCA-STEPHANIE, et al.
Publicado: (2014)

Re-Audit of Prescribing Responsibility for Antipsychotic Depots for Shared Care Patients(PRAD-SCP)
por: Ziriki, Ayebakari, et al.
Publicado: (2023)

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
por: Riboldi, Ilaria, et al.
Publicado: (2022)

Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India
por: Raghavan, Vijaya, et al.
Publicado: (2020)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
por: Peng, Xiaomei, et al.
Publicado: (2011)

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients
por: Ascher-Svanum, Haya, et al.
Publicado: (2009)

Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team
por: Waterman, Harry, et al.
Publicado: (2023)

S6. SLEEP ENDOPHENOTYPES OF SCHIZOPHRENIA: A HIGH-DENSITY EEG STUDY IN DRUG-NAïVE, FIRST EPISODE PSYCHOSIS PATIENTS
por: Castelnovo, Anna, et al.
Publicado: (2020)

Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes
por: Sam, Susan, et al.
Publicado: (2009)

Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study
por: Ahmadkhaniha, Hamid-Reza, et al.
Publicado: (2014)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
por: Machado-Duque, Manuel Enrique, et al.
Publicado: (2021)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
por: Potempa, Christoph, et al.
Publicado: (2018)

Improving Cardiac Monitoring for Patients on Depot Antipsychotic Medication in a Mental Health Service for Homeless People
por: Hall, Hugh, et al.
Publicado: (2023)

National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis
por: Luo, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tph9cjcb321i8elmv9ioi3mu76